In the literature, SRGN is an important poor prognostic marker in lung adenocarcinoma negative for TTF1 expression (thyroid transcription factor 1), while in nasopharyngeal carcinoma, it was reported to be highly expressed in metastatic cases [36]. This evidence concerns the gene TTF1 and nasopharyngeal carcinoma.